Reciprocal cellular cross-talk within the tumor microenvironment promotes oncolytic virus activity.
Saved in:
| Title: | Reciprocal cellular cross-talk within the tumor microenvironment promotes oncolytic virus activity. |
|---|---|
| Authors: | Ilkow CS; 1] Centre for Innovative Cancer Therapeutics, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada. [2] Department of Biochemistry, Immunology and Microbiology, University of Ottawa, Ottawa, Ontario, Canada., Marguerie M; 1] Centre for Innovative Cancer Therapeutics, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada. [2] Department of Biochemistry, Immunology and Microbiology, University of Ottawa, Ottawa, Ontario, Canada., Batenchuk C; 1] Centre for Innovative Cancer Therapeutics, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada. [2] Department of Biochemistry, Immunology and Microbiology, University of Ottawa, Ottawa, Ontario, Canada., Mayer J; Centre for Innovative Cancer Therapeutics, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada., Ben Neriah D; Centre for Innovative Cancer Therapeutics, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada., Cousineau S; Centre for Innovative Cancer Therapeutics, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada., Falls T; Centre for Innovative Cancer Therapeutics, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada., Jennings VA; Centre for Innovative Cancer Therapeutics, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada., Boileau M; Centre for Innovative Cancer Therapeutics, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada., Bellamy D; Centre for Innovative Cancer Therapeutics, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada., Bastin D; Centre for Innovative Cancer Therapeutics, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada., de Souza CT; Centre for Innovative Cancer Therapeutics, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada., Alkayyal A; 1] Centre for Innovative Cancer Therapeutics, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada. [2] Department of Medical Laboratory Technology, Faculty of Applied Medical Sciences, University of Tabuk, Tabuk, Saudi Arabia., Zhang J; 1] Centre for Innovative Cancer Therapeutics, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada. [2] Department of Neurosurgery, the Second Hospital of Shandong University, Jinan, Shandong, China., Le Boeuf F; 1] Centre for Innovative Cancer Therapeutics, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada. [2] Department of Biochemistry, Immunology and Microbiology, University of Ottawa, Ottawa, Ontario, Canada., Arulanandam R; 1] Centre for Innovative Cancer Therapeutics, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada. [2] Department of Biochemistry, Immunology and Microbiology, University of Ottawa, Ottawa, Ontario, Canada., Stubbert L; 1] Centre for Innovative Cancer Therapeutics, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada. [2] Department of Biochemistry, Immunology and Microbiology, University of Ottawa, Ottawa, Ontario, Canada., Sampath P; 1] University of Pittsburgh Cancer Institute, University of Pittsburgh, Pittsburgh, Pennsylvania, USA. [2] Department of Surgery, University of Pittsburgh, Pittsburgh, Pennsylvania, USA. [3] Department of Immunology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA., Thorne SH; 1] University of Pittsburgh Cancer Institute, University of Pittsburgh, Pittsburgh, Pennsylvania, USA. [2] Department of Surgery, University of Pittsburgh, Pittsburgh, Pennsylvania, USA. [3] Department of Immunology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA., Paramanthan P; The Ottawa Hospital, Division of Gastroenterology, Ottawa, Ontario, Canada., Chatterjee A; The Ottawa Hospital, Division of Gastroenterology, Ottawa, Ontario, Canada., Strieter RM; Global Translational Medicine, Novartis Institutes for BioMedical Research, Cambridge, Massachusetts, USA., Burdick M; Department of Medicine, Pulmonary and Critical Care, University of Virginia, Charlottesville, Virginia, USA., Addison CL; 1] Centre for Innovative Cancer Therapeutics, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada. [2] Department of Biochemistry, Immunology and Microbiology, University of Ottawa, Ottawa, Ontario, Canada., Stojdl DF; 1] Department of Biochemistry, Immunology and Microbiology, University of Ottawa, Ottawa, Ontario, Canada. [2] Children's Hospital of Eastern Ontario Research Institute, Ottawa, Ontario, Canada., Atkins HL; Centre for Innovative Cancer Therapeutics, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada., Auer RC; Centre for Innovative Cancer Therapeutics, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada., Diallo JS; Centre for Innovative Cancer Therapeutics, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada., Lichty BD; McMaster Immunology Research Centre, McMaster University, Hamilton, Ontario, Canada., Bell JC; 1] Centre for Innovative Cancer Therapeutics, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada. [2] Department of Biochemistry, Immunology and Microbiology, University of Ottawa, Ottawa, Ontario, Canada. |
| Source: | Nature medicine [Nat Med] 2015 May; Vol. 21 (5), pp. 530-6. Date of Electronic Publication: 2015 Apr 20. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1546-170X (Electronic) Linking ISSN: 10788956 NLM ISO Abbreviation: Nat Med Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 25894825 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Reciprocal cellular cross-talk within the tumor microenvironment promotes oncolytic virus activity. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Ilkow+CS%22">Ilkow CS</searchLink>; 1] Centre for Innovative Cancer Therapeutics, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada. [2] Department of Biochemistry, Immunology and Microbiology, University of Ottawa, Ottawa, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Marguerie+M%22">Marguerie M</searchLink>; 1] Centre for Innovative Cancer Therapeutics, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada. [2] Department of Biochemistry, Immunology and Microbiology, University of Ottawa, Ottawa, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Batenchuk+C%22">Batenchuk C</searchLink>; 1] Centre for Innovative Cancer Therapeutics, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada. [2] Department of Biochemistry, Immunology and Microbiology, University of Ottawa, Ottawa, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Mayer+J%22">Mayer J</searchLink>; Centre for Innovative Cancer Therapeutics, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Ben+Neriah+D%22">Ben Neriah D</searchLink>; Centre for Innovative Cancer Therapeutics, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Cousineau+S%22">Cousineau S</searchLink>; Centre for Innovative Cancer Therapeutics, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Falls+T%22">Falls T</searchLink>; Centre for Innovative Cancer Therapeutics, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Jennings+VA%22">Jennings VA</searchLink>; Centre for Innovative Cancer Therapeutics, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Boileau+M%22">Boileau M</searchLink>; Centre for Innovative Cancer Therapeutics, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Bellamy+D%22">Bellamy D</searchLink>; Centre for Innovative Cancer Therapeutics, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Bastin+D%22">Bastin D</searchLink>; Centre for Innovative Cancer Therapeutics, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22de+Souza+CT%22">de Souza CT</searchLink>; Centre for Innovative Cancer Therapeutics, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Alkayyal+A%22">Alkayyal A</searchLink>; 1] Centre for Innovative Cancer Therapeutics, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada. [2] Department of Medical Laboratory Technology, Faculty of Applied Medical Sciences, University of Tabuk, Tabuk, Saudi Arabia.<br /><searchLink fieldCode="AU" term="%22Zhang+J%22">Zhang J</searchLink>; 1] Centre for Innovative Cancer Therapeutics, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada. [2] Department of Neurosurgery, the Second Hospital of Shandong University, Jinan, Shandong, China.<br /><searchLink fieldCode="AU" term="%22Le+Boeuf+F%22">Le Boeuf F</searchLink>; 1] Centre for Innovative Cancer Therapeutics, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada. [2] Department of Biochemistry, Immunology and Microbiology, University of Ottawa, Ottawa, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Arulanandam+R%22">Arulanandam R</searchLink>; 1] Centre for Innovative Cancer Therapeutics, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada. [2] Department of Biochemistry, Immunology and Microbiology, University of Ottawa, Ottawa, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Stubbert+L%22">Stubbert L</searchLink>; 1] Centre for Innovative Cancer Therapeutics, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada. [2] Department of Biochemistry, Immunology and Microbiology, University of Ottawa, Ottawa, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Sampath+P%22">Sampath P</searchLink>; 1] University of Pittsburgh Cancer Institute, University of Pittsburgh, Pittsburgh, Pennsylvania, USA. [2] Department of Surgery, University of Pittsburgh, Pittsburgh, Pennsylvania, USA. [3] Department of Immunology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.<br /><searchLink fieldCode="AU" term="%22Thorne+SH%22">Thorne SH</searchLink>; 1] University of Pittsburgh Cancer Institute, University of Pittsburgh, Pittsburgh, Pennsylvania, USA. [2] Department of Surgery, University of Pittsburgh, Pittsburgh, Pennsylvania, USA. [3] Department of Immunology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.<br /><searchLink fieldCode="AU" term="%22Paramanthan+P%22">Paramanthan P</searchLink>; The Ottawa Hospital, Division of Gastroenterology, Ottawa, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Chatterjee+A%22">Chatterjee A</searchLink>; The Ottawa Hospital, Division of Gastroenterology, Ottawa, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Strieter+RM%22">Strieter RM</searchLink>; Global Translational Medicine, Novartis Institutes for BioMedical Research, Cambridge, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Burdick+M%22">Burdick M</searchLink>; Department of Medicine, Pulmonary and Critical Care, University of Virginia, Charlottesville, Virginia, USA.<br /><searchLink fieldCode="AU" term="%22Addison+CL%22">Addison CL</searchLink>; 1] Centre for Innovative Cancer Therapeutics, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada. [2] Department of Biochemistry, Immunology and Microbiology, University of Ottawa, Ottawa, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Stojdl+DF%22">Stojdl DF</searchLink>; 1] Department of Biochemistry, Immunology and Microbiology, University of Ottawa, Ottawa, Ontario, Canada. [2] Children's Hospital of Eastern Ontario Research Institute, Ottawa, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Atkins+HL%22">Atkins HL</searchLink>; Centre for Innovative Cancer Therapeutics, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Auer+RC%22">Auer RC</searchLink>; Centre for Innovative Cancer Therapeutics, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Diallo+JS%22">Diallo JS</searchLink>; Centre for Innovative Cancer Therapeutics, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Lichty+BD%22">Lichty BD</searchLink>; McMaster Immunology Research Centre, McMaster University, Hamilton, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Bell+JC%22">Bell JC</searchLink>; 1] Centre for Innovative Cancer Therapeutics, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada. [2] Department of Biochemistry, Immunology and Microbiology, University of Ottawa, Ottawa, Ontario, Canada. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229502015%22">Nature medicine</searchLink> [Nat Med] 2015 May; Vol. 21 (5), pp. 530-6. <i>Date of Electronic Publication: </i>2015 Apr 20. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Publishing+Company%22">Nature Publishing Company </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9502015 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1546-170X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2210788956%22">10788956 </searchLink><i>NLM ISO Abbreviation: </i>Nat Med <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=25894825 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1038/nm.3848 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 530 Titles: – TitleFull: Reciprocal cellular cross-talk within the tumor microenvironment promotes oncolytic virus activity. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Ilkow CS – PersonEntity: Name: NameFull: Marguerie M – PersonEntity: Name: NameFull: Batenchuk C – PersonEntity: Name: NameFull: Mayer J – PersonEntity: Name: NameFull: Ben Neriah D – PersonEntity: Name: NameFull: Cousineau S – PersonEntity: Name: NameFull: Falls T – PersonEntity: Name: NameFull: Jennings VA – PersonEntity: Name: NameFull: Boileau M – PersonEntity: Name: NameFull: Bellamy D – PersonEntity: Name: NameFull: Bastin D – PersonEntity: Name: NameFull: de Souza CT – PersonEntity: Name: NameFull: Alkayyal A – PersonEntity: Name: NameFull: Zhang J – PersonEntity: Name: NameFull: Le Boeuf F – PersonEntity: Name: NameFull: Arulanandam R – PersonEntity: Name: NameFull: Stubbert L – PersonEntity: Name: NameFull: Sampath P – PersonEntity: Name: NameFull: Thorne SH – PersonEntity: Name: NameFull: Paramanthan P – PersonEntity: Name: NameFull: Chatterjee A – PersonEntity: Name: NameFull: Strieter RM – PersonEntity: Name: NameFull: Burdick M – PersonEntity: Name: NameFull: Addison CL – PersonEntity: Name: NameFull: Stojdl DF – PersonEntity: Name: NameFull: Atkins HL – PersonEntity: Name: NameFull: Auer RC – PersonEntity: Name: NameFull: Diallo JS – PersonEntity: Name: NameFull: Lichty BD – PersonEntity: Name: NameFull: Bell JC IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 05 Text: 2015 May Type: published Y: 2015 Identifiers: – Type: issn-electronic Value: 1546-170X Numbering: – Type: volume Value: 21 – Type: issue Value: 5 Titles: – TitleFull: Nature medicine Type: main |
| ResultId | 1 |